{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:06:51Z","timestamp":1771668411828,"version":"3.50.1"},"reference-count":99,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.ygyno.2008.09.030","type":"journal-article","created":{"date-parts":[[2008,11,13]],"date-time":"2008-11-13T07:22:01Z","timestamp":1226560921000},"page":"663-672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["The quagmire of hCG and hCG testing in gynecologic oncology"],"prefix":"10.1016","volume":"112","author":[{"given":"Carolyn Y.","family":"Muller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence A.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2008.09.030_bib1","first-page":"144","article-title":"Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG-regulated neoplasia","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib2","first-page":"1553","article-title":"The increase in bladder carcinoma cell population induced by the free beta subunit of hCG is a result of an anti-apoptosis effect and not cell proliferation","volume":"82","author":"Butler","year":"2000","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.ygyno.2008.09.030_bib3","first-page":"499","article-title":"Hyperglycosylated hCG and its free \u03b2-subunit, tumor markers and tumor promoters: a review","volume":"53","author":"Cole","year":"2008","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2008.09.030_bib4","first-page":"1055","article-title":"Exogenous stimulation of corpus luteum formation in the rabbit: influence of extracts of human placenta, decidua, fetus, hydatid mole, and corpus luteum on the rabbit gonad","volume":"16","author":"Hirose","year":"1920","journal-title":"J. Jpn. Gynecol. Soc."},{"key":"10.1016\/j.ygyno.2008.09.030_bib5","first-page":"651","article-title":"The expression of human chorionic gonadotropin\/luteinizing hormone receptors in human endometrial and myometrial blood vessels","volume":"75","author":"Lei","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl A","key":"10.1016\/j.ygyno.2008.09.030_bib6","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.placenta.2007.02.002","article-title":"HCG in the regulation of placental angiogenesis. Results of an in vitro study","volume":"28","author":"Herr","year":"2007","journal-title":"Placenta"},{"issue":"Suppl 1","key":"10.1016\/j.ygyno.2008.09.030_bib7","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S0301-2115(03)00168-4","article-title":"Angiogenesis and vasculogenesis in pregnancy","volume":"110","author":"Zygmunt","year":"2003","journal-title":"Euro. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib8","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1210\/jc.2002-020642","article-title":"Characterization of human chorionic gonadotropin as a novel angiogenic factor","volume":"87","author":"Zygmunt","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ygyno.2008.09.030_bib9","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.fertnstert.2007.03.010","article-title":"Hyperglycosylated hCG the source of pregnancy failures","volume":"89","author":"Sasaki","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ygyno.2008.09.030_bib10","first-page":"150","article-title":"Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0009-9120(03)00108-5","article-title":"Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection","volume":"36","author":"Cole","year":"2003","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ygyno.2008.09.030_bib12","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/(SICI)1097-0223(199812)18:12<1232::AID-PD439>3.0.CO;2-Z","article-title":"Differential urinary gonadotrophin profiles in early pregnancy and early pregnancy loss","volume":"18","author":"O'Connor","year":"1998","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.ygyno.2008.09.030_bib13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.clinbiochem.2006.03.020","article-title":"A single serum test for measuring pregnancy outcome with high predictive value","volume":"39","author":"Sutton-Riley","year":"2006","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ygyno.2008.09.030_bib14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1210\/jcem-65-4-811","article-title":"The O-linked oligosaccharide structures are striking different on pregnancy and choriocarcinoma hCG","volume":"65","author":"Cole","year":"1987","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ygyno.2008.09.030_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02778058","article-title":"Carbohydrate and peptide structure of the \u03b1- and \u03b2-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma","volume":"7","author":"Elliott","year":"1997","journal-title":"Endocrine"},{"key":"10.1016\/j.ygyno.2008.09.030_bib16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0925-4439(99)00060-5","article-title":"Structure pathology and function of the N-linked sugar chains of hCG","volume":"1455","author":"Kobata","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ygyno.2008.09.030_bib17","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/glycob\/cwl034","article-title":"Site-specific glycan analysis of human chorionic gonadotropin \u03b2-subunit from malignancies and pregnancy by liquid chromatography-electrospray mass spectrometry","volume":"16","author":"Valmu","year":"2006","journal-title":"Glycobiology"},{"key":"10.1016\/j.ygyno.2008.09.030_bib18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0090-8258(88)90273-9","article-title":"Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system: I. Sensitivity and specificity, comparison with other markers","volume":"31","author":"Cole","year":"1988","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib19","first-page":"919","article-title":"Hyperglycosylated hCG (hCG-H) in gestational implantation and in choriocarcinoma and testicular germ cell malignancy tumorigenesis","volume":"51","author":"Cole","year":"2006","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2008.09.030_bib20","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1210\/jc.2004-2458","article-title":"Transfection of antisense chorionic gonadotropin \u03b2 gene into choriocarcinoma cells suppresses the cell proliferation and induces apoptosis","volume":"90","author":"Hamade","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ygyno.2008.09.030_bib21","first-page":"147","article-title":"Human chorionic gonadotropin promotes tumorigenesis of choriocarcinoma JAR cells","volume":"13","author":"Lei","year":"1999","journal-title":"Troph. Res."},{"key":"10.1016\/j.ygyno.2008.09.030_bib22","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1210\/en.2007-0286","article-title":"Human chorionic gonadotropin produced by the invasive trophoblast but not the villous trophoblast promotes cell invasion and is down-regulated by peroxisome proliferator-activated receptor-a","volume":"148","author":"Handshuh","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ygyno.2008.09.030_bib23","first-page":"4628","article-title":"Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease","volume":"52","author":"Alfthan","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2008.09.030_bib24","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/0140-6736(93)90872-E","article-title":"Free hCG beta subunit as tumour marker in urothelial cancer","volume":"341","author":"Marcillac","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2008.09.030_bib25","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/1097-0142(19951015)76:8<1299::AID-CNCR2820760802>3.0.CO;2-L","article-title":"Have we found the \u201cdefinitive cancer biomarker\u201d? The diagnostic and therapeutic implications of human chorionic gonadotropin-beta statement as a key to malignancy","volume":"76","author":"Regelson","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.09.030_bib26","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1002\/(SICI)1097-0142(19961201)78:11<2388::AID-CNCR18>3.0.CO;2-X","article-title":"Metastatic phenotype correlates with high expression of membrane-associated complete \u03b2-human chorionic gonadotropin in vivo","volume":"78","author":"Acevedo","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.09.030_bib27","first-page":"161","article-title":"Human chorionic gonadotrophin and its fragments as markers of prognosis in bladder cancer","volume":"7","author":"Iles","year":"1995","journal-title":"Tumour Marker Updat."},{"key":"10.1016\/j.ygyno.2008.09.030_bib28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.mce.2006.02.019","article-title":"Ectopic hCG\u03b2 expression by epithelial cancer: malignant behavior metastasis and inhibition of tumor cell apoptosis","volume":"260","author":"Iles","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib29","doi-asserted-by":"crossref","unstructured":"Li D, Wen X, Ghali L, Al-Shalabi FM, Docherty SM, Purkis P, et al. hCG\u03b2 expression by cervical squamous carcinoma \u2014 in vivo histological association with tumor invasion and apoptosis. Histopathology 2008;53(2):147\u201355.","DOI":"10.1111\/j.1365-2559.2008.03082.x"},{"key":"10.1016\/j.ygyno.2008.09.030_bib30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ygyno.2005.12.048","article-title":"Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib31","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/286714a0","article-title":"Mechanism of origin of complete moles","volume":"286","author":"Jacobs","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2008.09.030_bib32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0002-9378(81)90684-0","article-title":"Genesis of 46,XY hydatidiform mole","volume":"141","author":"Pattillo","year":"1981","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0002-9378(78)90829-3","article-title":"The syndromes of hydatidiform mole: I. Cytogenetic and morphologic correlations","volume":"131","author":"Szulman","year":"1982","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0002-9378(93)90494-4","article-title":"Rapid diagnosis and classification of hydatidiform moles with polymerase chain reaction","volume":"168","author":"Fisher","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib35","doi-asserted-by":"crossref","unstructured":"Buckley J. Epidemiology of gestational trophoblastic diseases. In: Szulman AE, Buchsbaum H, editors. Gestational trophoblastic diseases. Springer-Verlag, NY, pp 8\u201326.","DOI":"10.1007\/978-1-4612-4698-5_2"},{"key":"10.1016\/j.ygyno.2008.09.030_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(16)44829-6","article-title":"Hormonal evaluation of early pregnancy","volume":"34","author":"Batzer","year":"1980","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ygyno.2008.09.030_bib37","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1093\/clinchem\/43.12.2233","article-title":"Immunoassay of hCG, its free subunits and metabolites","volume":"43","author":"Cole","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ygyno.2008.09.030_bib38","first-page":"77235","article-title":"Hydatidiform mole with non-metastatic pulmonary complication and false low level of hCG","author":"Flam","year":"1998","journal-title":"Euro. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib39","first-page":"402","article-title":"Clinicopathologic study of 153 cases of complete hydatidiform mole (1980\u20131990): histologic grade lacks prognostic significance","volume":"78","author":"Genest","year":"1991","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00006250-198003000-00015","article-title":"Prospective follow-up of patients with hydatidiform mole","volume":"55","author":"Menczer","year":"1980","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib41","first-page":"812","article-title":"Management of GTD and other case with low serum levels of human chorionic gonadotropin","volume":"51","author":"Khanlian","year":"2006","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2008.09.030_bib42","first-page":"634","article-title":"Management of complete molar pregnancy","volume":"32","author":"Berkowitz","year":"1987","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2008.09.030_bib43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1530\/eje.1.01997","article-title":"Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG \u03b1- and \u03b2-subunits, and their ratios","volume":"153","author":"van Trommel","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib44","first-page":"78","article-title":"Hydatidiform mole and gestational trophoblastic disease in Southern Connecticut","volume":"59","author":"Kohorn","year":"1982","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib45","series-title":"Gestational trophoblastic neoplasm: clinical principles of diagnosis and management","first-page":"143","article-title":"The diagnosis and management of molar pregnancy","author":"Goldstein","year":"1982"},{"key":"10.1016\/j.ygyno.2008.09.030_bib46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0140-6736(00)02432-6","article-title":"Choriocarcinoma and partial hydatidiform mole","volume":"356","author":"Seckl","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2008.09.030_bib47","series-title":"Gestational trophoblastic disease","first-page":"229","article-title":"Presentation and management of persistent gestational trophoblastic disease (GTD) and gestational trophoblastic tumor (GTT) in the United Kingdom","author":"Newlands","year":"2002"},{"key":"10.1016\/j.ygyno.2008.09.030_bib48","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/oxfordjournals.aje.a114337","article-title":"Choriocarcinoma incidence in the United States","volume":"123","author":"Brinton","year":"1986","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1067\/mob.2003.39","article-title":"Ethnic differences in risk for gestational trophoblastic disease in New Mexico: a 25-year population-based study","volume":"188","author":"Smith","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib50","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ygyno.2004.02.018","article-title":"Survival rates of patients with choriocarcinoma treated with chemotherapy without hysterectomy: effects of anticancer agents on subsequent births","volume":"93","author":"Goto","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib51","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/ijgc-00009577-200605000-00074","article-title":"Results with EMA\/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia","volume":"16","author":"Turan","year":"2006","journal-title":"Int. J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib52","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1067\/mob.2003.271","article-title":"Persistent low levels of hCG: a pre-malignant gestational trophoblastic disease","volume":"188","author":"Khanlian","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib53","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00003081-200309000-00005","article-title":"hCG tests in the management of gestational trophoblastic diseases","volume":"46","author":"Cole","year":"2003","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib54","series-title":"Gestational trophoblastic disease","first-page":"130","article-title":"Use of hCG tests for evaluating trophoblastic diseases: choosing an appropriate hCG assay, false detection of hCG, unexplained elevated hCG, and quiescent trophoblastic disease","author":"Cole","year":"2002"},{"key":"10.1016\/j.ygyno.2008.09.030_bib55","unstructured":"Hancock BW, Tidy JA. Clinical management of persistent low-level hCG elevation. Trophobl Dis Upd 4: 5\u20136."},{"key":"10.1016\/j.ygyno.2008.09.030_bib56","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/gyno.2002.6622","article-title":"Persistent low-level \u201creal\u201d human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma","volume":"85","author":"Kohorn","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib57","series-title":"Gestational trophoblastic disease","first-page":"329","article-title":"Placental site trophoblastic tumors","author":"Gillespie","year":"2002"},{"key":"10.1016\/j.ygyno.2008.09.030_bib58","first-page":"460","article-title":"Twenty-five years' clinical experience with placental site trophoblastic tumors","volume":"47","author":"Papadopoulos","year":"2002","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2008.09.030_bib59","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2005.12.046","article-title":"Gestational trophoblastic diseases: 3. Human chorionic gonadotropin free \u03b2-subunit a reliable marker of placental site trophoblastic tumors","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib60","first-page":"457","article-title":"Blood test for placental site trophoblastic tumor (PSTT) and for non-trophoblastic malignancy for evaluating patients with low positive hCG results","volume":"53","author":"Cole","year":"2008","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2008.09.030_bib61","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/gyno.1999.5438","article-title":"Following metastatic placental site trophoblastic tumor with urine \u03b2-core fragment","volume":"74","author":"Rinne","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib62","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1373\/clinchem.2003.026989","article-title":"Between-method variation in hCG test results","volume":"50","author":"Cole","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ygyno.2008.09.030_bib63","first-page":"217","article-title":"Selecting an appropriate hCG test for management of gestational trophoblastic diseases and cancer cases","volume":"51","author":"Cole","year":"2006","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2008.09.030_bib64","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mce.2006.05.010","article-title":"Determination of hyperglycosylated human chorionic gonadotropin produced by malignant gestational trophoblastic neoplasias and male germ cell tumors using a lectin-based immunoassay and surface plasmon resonance","volume":"260","author":"Kelly","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib65","first-page":"1471","article-title":"Characterization of immunoreactive hCG beta-subunit in cultured fluids of the cell lines derived from gynecologic malignant tumors","volume":"42","author":"Nishimura","year":"1990","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"key":"10.1016\/j.ygyno.2008.09.030_bib66","first-page":"3901","article-title":"Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms","volume":"52","author":"Marcillac","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2008.09.030_bib67","first-page":"69","article-title":"\u03b2-core fragment (\u03b2-core UGP or UGF)","volume":"6","author":"Cole","year":"1994","journal-title":"Tumour Marker Updat."},{"key":"10.1016\/j.ygyno.2008.09.030_bib68","first-page":"1520","article-title":"Immunoreactive human chorionic gonadotropin and its free beta subunit in serum and ascites of patients with malignant tumors","volume":"52","author":"Hoermann","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2008.09.030_bib69","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1002\/ijc.23322","article-title":"Combination of serum hCG beta and p53 tissue expression defines distinct subgroups of serous ovarian carcinoma","volume":"122","author":"Vartiainen","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2008.09.030_bib70","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ygyno.2007.04.022","article-title":"Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment","volume":"106","author":"Badgwell","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib71","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jpedsurg.2004.05.023","article-title":"A case of pediatric ovarian dysgerminoma associated with high serum levels and positive immunohistochemical staining of neuron-specific enolase","volume":"39","author":"Tatekawa","year":"2004","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.ygyno.2008.09.030_bib72","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1309\/LMR6YEJLP6QCDX93","article-title":"Endometrial adenocarcinoma associated with elevated serum concentrations of the free beta subunit of human chorionic gonadotropin","volume":"121","author":"Grenache","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib73","first-page":"122","article-title":"Ovarian tumour: ovarian pregnancy, diagnosis and management","volume":"30","author":"Tjalma","year":"2003","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000070656","article-title":"The expression of hCG receptor mRNA in four human ovarian cancer cell lines varies considerably under different experimental conditions","volume":"24","author":"Steinmeyer","year":"2003","journal-title":"Tumour Biol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib75","first-page":"88","article-title":"Circulating tumor markers and nuclear medicine imaging modalities: breast, prostate and ovarian cancer","volume":"46","author":"Ugrinska","year":"2002","journal-title":"Q. J. Nucl. Med."},{"key":"10.1016\/j.ygyno.2008.09.030_bib76","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/PL00012090","article-title":"Ovarian malignant mixed mesodermal tumor producing the free form of the beta-subunit of human chorionic gonadotropin","volume":"6","author":"Higashida","year":"2001","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib77","first-page":"629","article-title":"The beta-hCG subunit, CA 125 and CA 19-9 antigen in the women with non-trophoblastic malignancy of genital tract","volume":"72","author":"Piela","year":"2001","journal-title":"Ginekologia Polska"},{"key":"10.1016\/j.ygyno.2008.09.030_bib78","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0024-3205(00)00986-3","article-title":"Human chorionic gonadotropin beta-core fragment is directly produced by cancer cells","volume":"68","author":"Okamoto","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.ygyno.2008.09.030_bib79","first-page":"5551","article-title":"Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study","volume":"19","author":"Schutter","year":"1999","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2008.09.030_bib80","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0090-8258(90)90148-E","article-title":"Urinary gonadotropin fragment, a new tumor marker","volume":"36","author":"Nam","year":"1990","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib81","first-page":"4666","article-title":"Ectopic human chorionic gonadotrophin \u03b2 secretion by epithelial tumors and human chorionic gonadotrophin \u03b2-induced apoptosis in Karposi's sarcoma is there a connection?","volume":"9","author":"Butler","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2008.09.030_bib82","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/1097-0142(19830815)52:4<654::AID-CNCR2820520415>3.0.CO;2-S","article-title":"Molecular heterogeneity of human chorionic gonadotropin and its subunits in testicular cancer","volume":"52","author":"Mann","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.09.030_bib83","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2249.2005.02837.x","article-title":"Cunningham-Rundles C. Frequent false positive beta human chorionic gonadotropin in immunoglobulin A deficiency","volume":"141","author":"Knight","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib84","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1006\/gyno.1998.5181","article-title":"Phantom hCG and phantom choriocarcinoma","volume":"71","author":"Cole","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib85","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/clinchem\/45.2.313","article-title":"False positive hCG levels leading to unnecessary surgery and chemotherapy, and needless occurrences of diabetes and coma","volume":"45","author":"Cole","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ygyno.2008.09.030_bib86","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0140-6736(00)01324-6","article-title":"False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations","volume":"355","author":"Rotmensch","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2008.09.030_bib87","first-page":"9","article-title":"False positive or phantom hCG result: a serious problem","volume":"25","author":"Cole","year":"2001","journal-title":"Clin. Lab. Int."},{"key":"10.1016\/j.ygyno.2008.09.030_bib88","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00256399","article-title":"Falsely elevated results of radioimmunoassays using double antibody method: arguments for a third anti-rabbit IgG antibody present in certain human sera","volume":"7","author":"Baulieu","year":"1982","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.ygyno.2008.09.030_bib89","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1001\/jama.1982.03330190053031","article-title":"Heterophilic antibodies interfering with radioimmunoassay","volume":"248","author":"Vladutiu","year":"1982","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ygyno.2008.09.030_bib90","first-page":"211","article-title":"Discordant human chorionic gonadotropin results: causes and solutions","volume":"65","author":"Hussa","year":"1985","journal-title":"Obstet. Gyncol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib91","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/clinchem\/29.10.1871","article-title":"False positive results for choriogonadotropin in serum","volume":"29","author":"Garrett","year":"1983","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ygyno.2008.09.030_bib92","first-page":"843","article-title":"Falsely elevated human chorionic gonadotropin leading to unnecessary therapy","volume":"98","author":"Olsen","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib93","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.clinbiochem.2004.03.001","article-title":"Easy fix for clinical laboratories for the false positive defect with the Abbott AxSym total \u03b2-hCG test","volume":"37","author":"Cole","year":"2004","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ygyno.2008.09.030_bib94","unstructured":"Cole LA, Ladner LG, Byrn FW. The normal variabilities of the menstrual cycle. Fertil Steril in press [2008 April 21, Electronic publication ahead of print]."},{"key":"10.1016\/j.ygyno.2008.09.030_bib95","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/BF01539478","article-title":"Chromosome assignment of genes encoding the alpha and beta subunits of glycoprotein hormones in man and mouse","volume":"9","author":"Naylor","year":"1983","journal-title":"Somatic Cell Genet."},{"key":"10.1016\/j.ygyno.2008.09.030_bib96","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1016\/S0021-9258(17)38469-7","article-title":"A map of the hCG beta-LH beta gene cluster","volume":"13","author":"Policastro","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2008.09.030_bib97","unstructured":"Cole LA, Khanlian SA, Muller C. Normal production of human chorionic gonadotropin in perimenopausal and menopausal women and following oophorectomy. Intl J Gyn Cancer in press."},{"key":"10.1016\/j.ygyno.2008.09.030_bib98","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ajog.2007.09.034","article-title":"Detection of hCG peri- or post-menopause an unnecessary source of alarm","volume":"198","author":"Cole","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.09.030_bib99","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJMc066500","article-title":"Normal production of hCG in menopause: a medical management dilemma","volume":"356","author":"Cole","year":"2007","journal-title":"N. Eng. J. Med."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808007919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808007919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:28:38Z","timestamp":1758770918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808007919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0090825808007919"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.09.030","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The quagmire of hCG and hCG testing in gynecologic oncology","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}